 | • レポートコード：GIR-23F3415 • 出版社/出版日：GlobalInfoResearch / 2023年2月 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医療機器 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Drug–Device Combination Products Market」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社（香港）の最新の調査によると、世界の医薬品・装置組み合わせ製品の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 医薬品・装置組み合わせ製品市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次を対象にします。 ・輸液ポンプ、整形外科コンビネーション製品、光線力学療法装置、経皮パッチ、薬剤溶出ステント、創傷ケア製品、吸入器、その他 アプリケーション別セグメントは次のように区分されます。 ・病院、診療所、その他 世界の医薬品・装置組み合わせ製品市場の主要なマーケットプレーヤーは以下のとおりです。 ・Abbott、Terumo Corporation、Stryker Corporation、Mylan、Medtronic、Allergan、Boston Scientific、Novartis、BD、Teleflex Incorporated 地域別セグメントは次の地域・国を対象にします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） ***** 目次(一部) ***** ・市場概要 - 医薬品・装置組み合わせ製品の概要 - タイプ別分析（2017年vs2021年vs2028年）：輸液ポンプ、整形外科コンビネーション製品、光線力学療法装置、経皮パッチ、薬剤溶出ステント、創傷ケア製品、吸入器、その他 - アプリケーション別分析（2017年vs2021年vs2028年）：病院、診療所、その他 - 世界の医薬品・装置組み合わせ製品市場規模・予測 - 世界の医薬品・装置組み合わせ製品生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Abbott、Terumo Corporation、Stryker Corporation、Mylan、Medtronic、Allergan、Boston Scientific、Novartis、BD、Teleflex Incorporated ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：輸液ポンプ、整形外科コンビネーション製品、光線力学療法装置、経皮パッチ、薬剤溶出ステント、創傷ケア製品、吸入器、その他 ・アプリケーション別分析2017年-2028年：病院、診療所、その他 ・医薬品・装置組み合わせ製品の北米市場分析 - 医薬品・装置組み合わせ製品の北米市場：タイプ別市場規模2017年-2028年 - 医薬品・装置組み合わせ製品の北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・医薬品・装置組み合わせ製品のヨーロッパ市場分析 - ：医薬品・装置組み合わせ製品のヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：医薬品・装置組み合わせ製品のヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・医薬品・装置組み合わせ製品のアジア太平洋市場分析 - 医薬品・装置組み合わせ製品のアジア太平洋市場：タイプ別市場規模2017年-2028年 - 医薬品・装置組み合わせ製品のアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・医薬品・装置組み合わせ製品の南米市場分析 - 医薬品・装置組み合わせ製品の南米市場：タイプ別市場規模2017年-2028年 - 医薬品・装置組み合わせ製品の南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・医薬品・装置組み合わせ製品の中東・アフリカ市場分析 - 医薬品・装置組み合わせ製品の中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 医薬品・装置組み合わせ製品の中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Drug–Device Combination Products market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Drug–Device Combination Products market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Drug–Device Combination Products global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Infusion Pumps segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Drug–Device Combination Products include Abbott, Terumo Corporation, Stryker Corporation, Mylan, and Medtronic, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Drug–Device Combination Products market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Infusion Pumps
Orthopedic Combination Products
Photodynamic Therapy Devices
Transdermal Patches
Drug Eluting Stents
Wound Care Products
Inhalers
Other
Market segment by Application can be divided into
Hospital
Clinic
Other
The key market players for global Drug–Device Combination Products market are listed below:
Abbott
Terumo Corporation
Stryker Corporation
Mylan
Medtronic
Allergan
Boston Scientific
Novartis
BD
Teleflex Incorporated
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Drug–Device Combination Products product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Drug–Device Combination Products, with price, sales, revenue and global market share of Drug–Device Combination Products from 2019 to 2022.
Chapter 3, the Drug–Device Combination Products competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Drug–Device Combination Products breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Drug–Device Combination Products market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Drug–Device Combination Products.
Chapter 13, 14, and 15, to describe Drug–Device Combination Products sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Drug–Device Combination Products Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Drug–Device Combination Products Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Infusion Pumps
1.2.3 Orthopedic Combination Products
1.2.4 Photodynamic Therapy Devices
1.2.5 Transdermal Patches
1.2.6 Drug Eluting Stents
1.2.7 Wound Care Products
1.2.8 Inhalers
1.2.9 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Drug–Device Combination Products Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Drug–Device Combination Products Market Size & Forecast
1.4.1 Global Drug–Device Combination Products Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Drug–Device Combination Products Sales in Volume (2017-2028)
1.4.3 Global Drug–Device Combination Products Price (2017-2028)
1.5 Global Drug–Device Combination Products Production Capacity Analysis
1.5.1 Global Drug–Device Combination Products Total Production Capacity (2017-2028)
1.5.2 Global Drug–Device Combination Products Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Drug–Device Combination Products Market Drivers
1.6.2 Drug–Device Combination Products Market Restraints
1.6.3 Drug–Device Combination Products Trends Analysis
2 Manufacturers Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Drug–Device Combination Products Product and Services
2.1.4 Abbott Drug–Device Combination Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Terumo Corporation
2.2.1 Terumo Corporation Details
2.2.2 Terumo Corporation Major Business
2.2.3 Terumo Corporation Drug–Device Combination Products Product and Services
2.2.4 Terumo Corporation Drug–Device Combination Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Stryker Corporation
2.3.1 Stryker Corporation Details
2.3.2 Stryker Corporation Major Business
2.3.3 Stryker Corporation Drug–Device Combination Products Product and Services
2.3.4 Stryker Corporation Drug–Device Combination Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Mylan
2.4.1 Mylan Details
2.4.2 Mylan Major Business
2.4.3 Mylan Drug–Device Combination Products Product and Services
2.4.4 Mylan Drug–Device Combination Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Medtronic
2.5.1 Medtronic Details
2.5.2 Medtronic Major Business
2.5.3 Medtronic Drug–Device Combination Products Product and Services
2.5.4 Medtronic Drug–Device Combination Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Allergan
2.6.1 Allergan Details
2.6.2 Allergan Major Business
2.6.3 Allergan Drug–Device Combination Products Product and Services
2.6.4 Allergan Drug–Device Combination Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Boston Scientific
2.7.1 Boston Scientific Details
2.7.2 Boston Scientific Major Business
2.7.3 Boston Scientific Drug–Device Combination Products Product and Services
2.7.4 Boston Scientific Drug–Device Combination Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Novartis
2.8.1 Novartis Details
2.8.2 Novartis Major Business
2.8.3 Novartis Drug–Device Combination Products Product and Services
2.8.4 Novartis Drug–Device Combination Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 BD
2.9.1 BD Details
2.9.2 BD Major Business
2.9.3 BD Drug–Device Combination Products Product and Services
2.9.4 BD Drug–Device Combination Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Teleflex Incorporated
2.10.1 Teleflex Incorporated Details
2.10.2 Teleflex Incorporated Major Business
2.10.3 Teleflex Incorporated Drug–Device Combination Products Product and Services
2.10.4 Teleflex Incorporated Drug–Device Combination Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Drug–Device Combination Products Breakdown Data by Manufacturer
3.1 Global Drug–Device Combination Products Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Drug–Device Combination Products Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Drug–Device Combination Products
3.4 Market Concentration Rate
3.4.1 Top 3 Drug–Device Combination Products Manufacturer Market Share in 2021
3.4.2 Top 6 Drug–Device Combination Products Manufacturer Market Share in 2021
3.5 Global Drug–Device Combination Products Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Drug–Device Combination Products Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Drug–Device Combination Products Market Size by Region
4.1.1 Global Drug–Device Combination Products Sales in Volume by Region (2017-2028)
4.1.2 Global Drug–Device Combination Products Revenue by Region (2017-2028)
4.2 North America Drug–Device Combination Products Revenue (2017-2028)
4.3 Europe Drug–Device Combination Products Revenue (2017-2028)
4.4 Asia-Pacific Drug–Device Combination Products Revenue (2017-2028)
4.5 South America Drug–Device Combination Products Revenue (2017-2028)
4.6 Middle East and Africa Drug–Device Combination Products Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Drug–Device Combination Products Sales in Volume by Type (2017-2028)
5.2 Global Drug–Device Combination Products Revenue by Type (2017-2028)
5.3 Global Drug–Device Combination Products Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Drug–Device Combination Products Sales in Volume by Application (2017-2028)
6.2 Global Drug–Device Combination Products Revenue by Application (2017-2028)
6.3 Global Drug–Device Combination Products Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Drug–Device Combination Products Sales by Type (2017-2028)
7.2 North America Drug–Device Combination Products Sales by Application (2017-2028)
7.3 North America Drug–Device Combination Products Market Size by Country
7.3.1 North America Drug–Device Combination Products Sales in Volume by Country (2017-2028)
7.3.2 North America Drug–Device Combination Products Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Drug–Device Combination Products Sales by Type (2017-2028)
8.2 Europe Drug–Device Combination Products Sales by Application (2017-2028)
8.3 Europe Drug–Device Combination Products Market Size by Country
8.3.1 Europe Drug–Device Combination Products Sales in Volume by Country (2017-2028)
8.3.2 Europe Drug–Device Combination Products Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Drug–Device Combination Products Sales by Type (2017-2028)
9.2 Asia-Pacific Drug–Device Combination Products Sales by Application (2017-2028)
9.3 Asia-Pacific Drug–Device Combination Products Market Size by Region
9.3.1 Asia-Pacific Drug–Device Combination Products Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Drug–Device Combination Products Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Drug–Device Combination Products Sales by Type (2017-2028)
10.2 South America Drug–Device Combination Products Sales by Application (2017-2028)
10.3 South America Drug–Device Combination Products Market Size by Country
10.3.1 South America Drug–Device Combination Products Sales in Volume by Country (2017-2028)
10.3.2 South America Drug–Device Combination Products Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Drug–Device Combination Products Sales by Type (2017-2028)
11.2 Middle East & Africa Drug–Device Combination Products Sales by Application (2017-2028)
11.3 Middle East & Africa Drug–Device Combination Products Market Size by Country
11.3.1 Middle East & Africa Drug–Device Combination Products Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Drug–Device Combination Products Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Drug–Device Combination Products and Key Manufacturers
12.2 Manufacturing Costs Percentage of Drug–Device Combination Products
12.3 Drug–Device Combination Products Production Process
12.4 Drug–Device Combination Products Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Drug–Device Combination Products Typical Distributors
13.3 Drug–Device Combination Products Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
Table 1. Global Drug–Device Combination Products Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Drug–Device Combination Products Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Abbott Basic Information, Manufacturing Base and Competitors
Table 4. Abbott Major Business
Table 5. Abbott Drug–Device Combination Products Product and Services
Table 6. Abbott Drug–Device Combination Products Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Terumo Corporation Basic Information, Manufacturing Base and Competitors
Table 8. Terumo Corporation Major Business
Table 9. Terumo Corporation Drug–Device Combination Products Product and Services
Table 10. Terumo Corporation Drug–Device Combination Products Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Stryker Corporation Basic Information, Manufacturing Base and Competitors
Table 12. Stryker Corporation Major Business
Table 13. Stryker Corporation Drug–Device Combination Products Product and Services
Table 14. Stryker Corporation Drug–Device Combination Products Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Mylan Basic Information, Manufacturing Base and Competitors
Table 16. Mylan Major Business
Table 17. Mylan Drug–Device Combination Products Product and Services
Table 18. Mylan Drug–Device Combination Products Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Medtronic Basic Information, Manufacturing Base and Competitors
Table 20. Medtronic Major Business
Table 21. Medtronic Drug–Device Combination Products Product and Services
Table 22. Medtronic Drug–Device Combination Products Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Allergan Basic Information, Manufacturing Base and Competitors
Table 24. Allergan Major Business
Table 25. Allergan Drug–Device Combination Products Product and Services
Table 26. Allergan Drug–Device Combination Products Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Boston Scientific Basic Information, Manufacturing Base and Competitors
Table 28. Boston Scientific Major Business
Table 29. Boston Scientific Drug–Device Combination Products Product and Services
Table 30. Boston Scientific Drug–Device Combination Products Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Novartis Basic Information, Manufacturing Base and Competitors
Table 32. Novartis Major Business
Table 33. Novartis Drug–Device Combination Products Product and Services
Table 34. Novartis Drug–Device Combination Products Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. BD Basic Information, Manufacturing Base and Competitors
Table 36. BD Major Business
Table 37. BD Drug–Device Combination Products Product and Services
Table 38. BD Drug–Device Combination Products Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Teleflex Incorporated Basic Information, Manufacturing Base and Competitors
Table 40. Teleflex Incorporated Major Business
Table 41. Teleflex Incorporated Drug–Device Combination Products Product and Services
Table 42. Teleflex Incorporated Drug–Device Combination Products Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Global Drug–Device Combination Products Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 44. Global Drug–Device Combination Products Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 45. Market Position of Manufacturers in Drug–Device Combination Products, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 46. Global Drug–Device Combination Products Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Drug–Device Combination Products Production Site of Key Manufacturer
Table 48. Drug–Device Combination Products New Entrant and Capacity Expansion Plans
Table 49. Drug–Device Combination Products Mergers & Acquisitions in the Past Five Years
Table 50. Global Drug–Device Combination Products Sales by Region (2017-2022) & (K Units)
Table 51. Global Drug–Device Combination Products Sales by Region (2023-2028) & (K Units)
Table 52. Global Drug–Device Combination Products Revenue by Region (2017-2022) & (USD Million)
Table 53. Global Drug–Device Combination Products Revenue by Region (2023-2028) & (USD Million)
Table 54. Global Drug–Device Combination Products Sales by Type (2017-2022) & (K Units)
Table 55. Global Drug–Device Combination Products Sales by Type (2023-2028) & (K Units)
Table 56. Global Drug–Device Combination Products Revenue by Type (2017-2022) & (USD Million)
Table 57. Global Drug–Device Combination Products Revenue by Type (2023-2028) & (USD Million)
Table 58. Global Drug–Device Combination Products Price by Type (2017-2022) & (USD/Unit)
Table 59. Global Drug–Device Combination Products Price by Type (2023-2028) & (USD/Unit)
Table 60. Global Drug–Device Combination Products Sales by Application (2017-2022) & (K Units)
Table 61. Global Drug–Device Combination Products Sales by Application (2023-2028) & (K Units)
Table 62. Global Drug–Device Combination Products Revenue by Application (2017-2022) & (USD Million)
Table 63. Global Drug–Device Combination Products Revenue by Application (2023-2028) & (USD Million)
Table 64. Global Drug–Device Combination Products Price by Application (2017-2022) & (USD/Unit)
Table 65. Global Drug–Device Combination Products Price by Application (2023-2028) & (USD/Unit)
Table 66. North America Drug–Device Combination Products Sales by Country (2017-2022) & (K Units)
Table 67. North America Drug–Device Combination Products Sales by Country (2023-2028) & (K Units)
Table 68. North America Drug–Device Combination Products Revenue by Country (2017-2022) & (USD Million)
Table 69. North America Drug–Device Combination Products Revenue by Country (2023-2028) & (USD Million)
Table 70. North America Drug–Device Combination Products Sales by Type (2017-2022) & (K Units)
Table 71. North America Drug–Device Combination Products Sales by Type (2023-2028) & (K Units)
Table 72. North America Drug–Device Combination Products Sales by Application (2017-2022) & (K Units)
Table 73. North America Drug–Device Combination Products Sales by Application (2023-2028) & (K Units)
Table 74. Europe Drug–Device Combination Products Sales by Country (2017-2022) & (K Units)
Table 75. Europe Drug–Device Combination Products Sales by Country (2023-2028) & (K Units)
Table 76. Europe Drug–Device Combination Products Revenue by Country (2017-2022) & (USD Million)
Table 77. Europe Drug–Device Combination Products Revenue by Country (2023-2028) & (USD Million)
Table 78. Europe Drug–Device Combination Products Sales by Type (2017-2022) & (K Units)
Table 79. Europe Drug–Device Combination Products Sales by Type (2023-2028) & (K Units)
Table 80. Europe Drug–Device Combination Products Sales by Application (2017-2022) & (K Units)
Table 81. Europe Drug–Device Combination Products Sales by Application (2023-2028) & (K Units)
Table 82. Asia-Pacific Drug–Device Combination Products Sales by Region (2017-2022) & (K Units)
Table 83. Asia-Pacific Drug–Device Combination Products Sales by Region (2023-2028) & (K Units)
Table 84. Asia-Pacific Drug–Device Combination Products Revenue by Region (2017-2022) & (USD Million)
Table 85. Asia-Pacific Drug–Device Combination Products Revenue by Region (2023-2028) & (USD Million)
Table 86. Asia-Pacific Drug–Device Combination Products Sales by Type (2017-2022) & (K Units)
Table 87. Asia-Pacific Drug–Device Combination Products Sales by Type (2023-2028) & (K Units)
Table 88. Asia-Pacific Drug–Device Combination Products Sales by Application (2017-2022) & (K Units)
Table 89. Asia-Pacific Drug–Device Combination Products Sales by Application (2023-2028) & (K Units)
Table 90. South America Drug–Device Combination Products Sales by Country (2017-2022) & (K Units)
Table 91. South America Drug–Device Combination Products Sales by Country (2023-2028) & (K Units)
Table 92. South America Drug–Device Combination Products Revenue by Country (2017-2022) & (USD Million)
Table 93. South America Drug–Device Combination Products Revenue by Country (2023-2028) & (USD Million)
Table 94. South America Drug–Device Combination Products Sales by Type (2017-2022) & (K Units)
Table 95. South America Drug–Device Combination Products Sales by Type (2023-2028) & (K Units)
Table 96. South America Drug–Device Combination Products Sales by Application (2017-2022) & (K Units)
Table 97. South America Drug–Device Combination Products Sales by Application (2023-2028) & (K Units)
Table 98. Middle East & Africa Drug–Device Combination Products Sales by Region (2017-2022) & (K Units)
Table 99. Middle East & Africa Drug–Device Combination Products Sales by Region (2023-2028) & (K Units)
Table 100. Middle East & Africa Drug–Device Combination Products Revenue by Region (2017-2022) & (USD Million)
Table 101. Middle East & Africa Drug–Device Combination Products Revenue by Region (2023-2028) & (USD Million)
Table 102. Middle East & Africa Drug–Device Combination Products Sales by Type (2017-2022) & (K Units)
Table 103. Middle East & Africa Drug–Device Combination Products Sales by Type (2023-2028) & (K Units)
Table 104. Middle East & Africa Drug–Device Combination Products Sales by Application (2017-2022) & (K Units)
Table 105. Middle East & Africa Drug–Device Combination Products Sales by Application (2023-2028) & (K Units)
Table 106. Drug–Device Combination Products Raw Material
Table 107. Key Manufacturers of Drug–Device Combination Products Raw Materials
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Drug–Device Combination Products Typical Distributors
Table 111. Drug–Device Combination Products Typical Customers
List of Figures
Figure 1. Drug–Device Combination Products Picture
Figure 2. Global Drug–Device Combination Products Revenue Market Share by Type in 2021
Figure 3. Infusion Pumps
Figure 4. Orthopedic Combination Products
Figure 5. Photodynamic Therapy Devices
Figure 6. Transdermal Patches
Figure 7. Drug Eluting Stents
Figure 8. Wound Care Products
Figure 9. Inhalers
Figure 10. Other
Figure 11. Global Drug–Device Combination Products Revenue Market Share by Application in 2021
Figure 12. Hospital
Figure 13. Clinic
Figure 14. Other
Figure 15. Global Drug–Device Combination Products Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 16. Global Drug–Device Combination Products Revenue and Forecast (2017-2028) & (USD Million)
Figure 17. Global Drug–Device Combination Products Sales (2017-2028) & (K Units)
Figure 18. Global Drug–Device Combination Products Price (2017-2028) & (USD/Unit)
Figure 19. Global Drug–Device Combination Products Production Capacity (2017-2028) & (K Units)
Figure 20. Global Drug–Device Combination Products Production Capacity by Geographic Region: 2022 VS 2028
Figure 21. Drug–Device Combination Products Market Drivers
Figure 22. Drug–Device Combination Products Market Restraints
Figure 23. Drug–Device Combination Products Market Trends
Figure 24. Global Drug–Device Combination Products Sales Market Share by Manufacturer in 2021
Figure 25. Global Drug–Device Combination Products Revenue Market Share by Manufacturer in 2021
Figure 26. Drug–Device Combination Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 27. Top 3 Drug–Device Combination Products Manufacturer (Revenue) Market Share in 2021
Figure 28. Top 6 Drug–Device Combination Products Manufacturer (Revenue) Market Share in 2021
Figure 29. Global Drug–Device Combination Products Sales Market Share by Region (2017-2028)
Figure 30. Global Drug–Device Combination Products Revenue Market Share by Region (2017-2028)
Figure 31. North America Drug–Device Combination Products Revenue (2017-2028) & (USD Million)
Figure 32. Europe Drug–Device Combination Products Revenue (2017-2028) & (USD Million)
Figure 33. Asia-Pacific Drug–Device Combination Products Revenue (2017-2028) & (USD Million)
Figure 34. South America Drug–Device Combination Products Revenue (2017-2028) & (USD Million)
Figure 35. Middle East & Africa Drug–Device Combination Products Revenue (2017-2028) & (USD Million)
Figure 36. Global Drug–Device Combination Products Sales Market Share by Type (2017-2028)
Figure 37. Global Drug–Device Combination Products Revenue Market Share by Type (2017-2028)
Figure 38. Global Drug–Device Combination Products Price by Type (2017-2028) & (USD/Unit)
Figure 39. Global Drug–Device Combination Products Sales Market Share by Application (2017-2028)
Figure 40. Global Drug–Device Combination Products Revenue Market Share by Application (2017-2028)
Figure 41. Global Drug–Device Combination Products Price by Application (2017-2028) & (USD/Unit)
Figure 42. North America Drug–Device Combination Products Sales Market Share by Type (2017-2028)
Figure 43. North America Drug–Device Combination Products Sales Market Share by Application (2017-2028)
Figure 44. North America Drug–Device Combination Products Sales Market Share by Country (2017-2028)
Figure 45. North America Drug–Device Combination Products Revenue Market Share by Country (2017-2028)
Figure 46. United States Drug–Device Combination Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Canada Drug–Device Combination Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Mexico Drug–Device Combination Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Europe Drug–Device Combination Products Sales Market Share by Type (2017-2028)
Figure 50. Europe Drug–Device Combination Products Sales Market Share by Application (2017-2028)
Figure 51. Europe Drug–Device Combination Products Sales Market Share by Country (2017-2028)
Figure 52. Europe Drug–Device Combination Products Revenue Market Share by Country (2017-2028)
Figure 53. Germany Drug–Device Combination Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. France Drug–Device Combination Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. United Kingdom Drug–Device Combination Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Russia Drug–Device Combination Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Italy Drug–Device Combination Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Asia-Pacific Drug–Device Combination Products Sales Market Share by Region (2017-2028)
Figure 59. Asia-Pacific Drug–Device Combination Products Sales Market Share by Application (2017-2028)
Figure 60. Asia-Pacific Drug–Device Combination Products Sales Market Share by Region (2017-2028)
Figure 61. Asia-Pacific Drug–Device Combination Products Revenue Market Share by Region (2017-2028)
Figure 62. China Drug–Device Combination Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Japan Drug–Device Combination Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Korea Drug–Device Combination Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. India Drug–Device Combination Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Southeast Asia Drug–Device Combination Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Australia Drug–Device Combination Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. South America Drug–Device Combination Products Sales Market Share by Type (2017-2028)
Figure 69. South America Drug–Device Combination Products Sales Market Share by Application (2017-2028)
Figure 70. South America Drug–Device Combination Products Sales Market Share by Country (2017-2028)
Figure 71. South America Drug–Device Combination Products Revenue Market Share by Country (2017-2028)
Figure 72. Brazil Drug–Device Combination Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Argentina Drug–Device Combination Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Middle East & Africa Drug–Device Combination Products Sales Market Share by Type (2017-2028)
Figure 75. Middle East & Africa Drug–Device Combination Products Sales Market Share by Application (2017-2028)
Figure 76. Middle East & Africa Drug–Device Combination Products Sales Market Share by Region (2017-2028)
Figure 77. Middle East & Africa Drug–Device Combination Products Revenue Market Share by Region (2017-2028)
Figure 78. Turkey Drug–Device Combination Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Egypt Drug–Device Combination Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Saudi Arabia Drug–Device Combination Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. South Africa Drug–Device Combination Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Manufacturing Cost Structure Analysis of Drug–Device Combination Products in 2021
Figure 83. Manufacturing Process Analysis of Drug–Device Combination Products
Figure 84. Drug–Device Combination Products Industrial Chain
Figure 85. Sales Channel: Direct Channel vs Indirect Channel
Figure 86. Methodology
Figure 87. Research Process and Data Source